HempNewsAudio – Youngevity International, Inc. (NASDAQ: YGYI) Seizing Opportunity in North American Cannabis Market

Related Editorial
All eyes are on Canada and the burgeoning North American cannabis market as the flood gates open and nationwide recreational legalization north of the U.S. border throws the recent $47.3 billion by 2027 forecast from Arcview Market Research into clear relief.

• Historic end of cannabis prohibition creates unprecedented market forces
• CBD could outpace broader market
• Direct selling in the digital age more relevant than ever
• Overlapping cultural vectors among core wellness and cannabis consumers
• Biopharma potential immense, nutritional potential immediately accessible commercially

Already running hot at $9.2 billion last year, the North American cannabis market appears to be just getting started. Youngevity International, Inc. (NASDAQ: YGYI) (YGYI Profile) is a particularly interesting player in this space that deserves further examination considering the company’s strong logistical footprint in direct selling, the success of a shrewd and comprehensive growth model in ground coffee retail, and an established presence as one of the most trusted names in nutritional supplements. INSYS Therapeutics, Inc. (NASDAQ: INSY) has a leading position in the development of pharmaceutical cannabinoids. Developers of MARINOL, the first synthetic tetrahydrocannabinol (THC) oral solution, AbbVie Inc. (NYSE: ABBV) has been ranked in the top five on Science magazine’s annual list of Top Science Employers. Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is known for transdermal cannabinoid therapies and recently reported the initiation of a first-of-its-kind clinical study using a novel pharmaceutically produced CBD targeting epilepsy and Fragile X syndrome. Cara Therapeutics, Inc. (NASDAQ: CARA) is at the forefront of preclinical work in selective cannabinoid receptor-modulating formulas that avoid interacting with receptors in the central nervous system.

To view the full editorial, visit http://cnw.fm/l3UbQ

About Youngevity International, Inc.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers proven products from the six top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The company was formed during the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness.

HW is where news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net